There are currently six companies that
are clients of the Innovation Center.
Founded in 2004 based on novel biomarker
technologies developed at the Cleveland Clinic.
The Company is involved in the discovery and validation
of molecular biomarkers and their development into
products that aid in the diagnosis and treatment
of a variety of diseases. PrognostiX recently received
FDA approval for their CardioMPO™ kit.
Mission is to create and develop
innovative vascular and cardiovascular surgical
products that improve surgical outcomes through
product longevity and cost effectiveness. The company’s
technology involves the incorporation of bovine
biological tissue, peritoneum, into several implantable
product applications - peripheral vascular stents,
dialysis a leg bypass grafts, percutaneous aortic
heart valves, and vascular patches. Year established:
2002
Advanced skin biopsy and wound healing
solutions to oncology, dermatology and primary care
physicians. Its first product, ExiClip™, is
a one-step device that delivers consistent and efficacious
results. The technology platform is disruptive with
the potential to significantly enhance patient outcomes.
Combining nanotechnology and
cell receptor targeting for improved pharmaceuticals
